Amendment #273 to H4200

Medicaid Reimbursement Criteria Change to Enable Patient Access to Medically Accurate Definitive Drug Testing Procedures to Avoid Unintended Prescription Overdoses

Mr. Cullinane of Boston moves to amend the bill by adding at the end thereof the following new outside section:

SECTION ##. The office of Medicaid is directed to amend its coverage policies for clinical urine drug testing, coverage and reimbursement to align with the Centers for Medicare and Medicaid  Services (CMS) guidelines and allow for reimbursement for definitive testing (also includes quantitative and confirmatory testing) sent directly to licensed clinical laboratories without prior presumptive testing being performed. 

To ensure appropriate and responsible use, medical necessity documentation and utilization frequency guidelines, as outlined by the Centers for Medicare and Medicaid Services (CMS), shall be implemented by the office of Medicaid."